(Q82371875)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20043025%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Respiratory syncytial virus market (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20043025%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Shane Storey

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20043025%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20043025%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Drug Discovery

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20043025%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20043025%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20043025%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

15-16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20043025%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrd3075

16 January 2020

exact match

0 references

cites work

Respiratory syncytial virus infection in adults

1 reference

Properties of human IgG1s engineered for enhanced binding to the neonatal Fc receptor (FcRn).

31 March 2020

1 reference

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

31 March 2020

1 reference

Challenges in developing a pediatric RSV vaccine

31 March 2020

1 reference

Emerging drugs for respiratory syncytial virus infection

31 March 2020

1 reference

1,4-benzodiazepines as inhibitors of respiratory syncytial virus. The identification of a clinical candidate

31 March 2020

1 reference

Inhibition of respiratory viruses by nasally administered siRNA.

31 March 2020

1 reference

Motavizumab for the prevention of respiratory syncytial virus infection in infants

31 March 2020

1 reference

Cost-effectiveness of palivizumab against respiratory syncytial viral infection in high-risk children in Austria

31 March 2020

1 reference

RSV infection in the adult population.

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20043025

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Impact of RSV: implications for managed care

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20043025

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Immunoprophylaxis of RSV infection: advancing from RSV-IGIV to palivizumab and motavizumab

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20043025

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRD3075

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20043025%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference